Recruiting
Phase 1
Phase 2

CDDP/TXT & Chemoradiation

Sponsor:

University of Vermont

Code:

NCT00982436

Conditions

Head and Neck Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Docetaxel/cisplatin

Radiotherapy

Carboplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-31. This information was provided to ClinicalTrials.gov by University of Vermont on 2012-03-22.